Browsing: Year

Axsome Therapeutics (NASDAQ: AXSM), a biotech company, has performed fairly well this year. The company’s shares are up 16% versus the S&P 500’s 11%. Could the stock rise even higher? Wall Street certainly thinks so. Axsome Therapeutics’ average price target (according to Yahoo! Finance) of $285.42 implies about a 37% upside from its current level.…

As Cebuana Lhuillier continues to evolve beyond its legacy as a pawnshop, Emirosco Michael Sena, First Vice President and Chief Marketing and Communications Officer, has played a central role in shaping how the brand communicates this transformation to millions of Filipinos. His work has centered on making financial solutions more relevant to everyday life, connecting…

Data intelligence firm 601 Analytics is hitting a new business stride. Co-founder Matthew Jafarian shared that the company saw a record financial year, coming in part through a growing client base with a hearty boost from its work around the FIFA 2026 Men’s World Cup.